Related Experiment Video

Updated: Apr 20, 2026

In Vivo Infection with Leishmania amazonensis to Evaluate Parasite Virulence in Mice
06:57

In Vivo Infection with Leishmania amazonensis to Evaluate Parasite Virulence in Mice

Published on: February 20, 2020

8.8K

Visceral leishmaniasis infection in a fingolimod-treated multiple sclerosis patient

A K Artemiadis1, G Nikolaou2, D Kolokythopoulos3

  • 11st Department of Neurology, Aeginition Hospital, School of Medicine, Kapodistrian University of Athens, Athens, Greece kmwartem@yahoo.com.

Multiple Sclerosis (Houndmills, Basingstoke, England)
|November 30, 2014
PubMed
Abstract

No abstract available in PubMed .

Keywords:
Visceralfingolimodinfectionleishmaniasismultiple sclerosisside-effect

More Related Videos

In Vivo Imaging of Leishmania infantum-infected Hamsters by Gingival Inoculation of Axenic Amastigotes Expressing Luciferase05:55

In Vivo Imaging of Leishmania infantum-infected Hamsters by Gingival Inoculation of Axenic Amastigotes Expressing Luciferase

Published on: April 4, 2025

934
Cutaneous Leishmaniasis in the Dorsal Skin of Hamsters: a Useful Model for the Screening of Antileishmanial Drugs11:36

Cutaneous Leishmaniasis in the Dorsal Skin of Hamsters: a Useful Model for the Screening of Antileishmanial Drugs

Published on: April 21, 2012

22.7K

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
4